Using a subsequent ARPI after progression on darolutamide plus ADT and docetaxel in the metastatic hormone-sensitive setting does not provide a survival advantage compared with using subsequent ...
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study ...
Adding Truqap to Faslodex improved outcomes in patients with locally advanced or metastatic HR-positive, HER2-negative breast cancer. Patients with HR-positive, HER2-negative locally advanced or ...
Fewer patients opt to skip therapy for their multiple myeloma (MM) despite progressive disease than previously thought, a new study suggests. A new report upends the conventional wisdom around the ...
If you’re thinking about going to therapy for the first time, you might feel a mix of emotions: excitement to get a professional’s take on issues that are bothering you, anxiety and awkwardness about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback